| 1 |
Tseng CN, Chen DY, Chang SH, Huang WK, Hsieh MJ, See LC. Ambient temperature effect on acute myocardial infarction by risk factors: daily data from 2000 to 2017, Taiwan, China. JACC Asia, 2023; 3(2):228-38.
|
| 2 |
Wang GM, Li Y, Wu S, Zheng W, Ma JJ, Xu F, et al. The combination of creatine kinase-myocardial band isoenzyme and point-of-care cardiac troponin/ contemporary cardiac troponin for the early diagnosis of acute myocardial infarction. World J Emerg Med. 2022; 13(3):163-8.
|
| 3 |
Hossain E, Islam K, Yeasmin F, Karim MR, Rahman M, Agarwal S, et al. Elevated levels of plasma big endothelin-1 and its relation to hypertension and skin lesions in individuals exposed to arsenic. Toxicol Appl Pharmacol. 2012; 259(2):187-94.
|
| 4 |
Chen Y, Li JX, Song Y, Xu JJ, Tang XF, Jiang L, et al. Plasma big endothelin-1 and stent thrombosis: an observational study in patients undergoing percutaneous coronary intervention in China. Thromb Res. 2017; 159:5-12.
doi: S0049-3848(17)30491-7
pmid: 28942357
|
| 5 |
Nanda NS, Bao M, Lin HN, Clauser K, Komuves L, Quertermous T, et al. Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation. J Biol Chem. 2005; 280(26):24680-9.
doi: 10.1074/jbc.M413411200
pmid: 15851471
|
| 6 |
Zhan QH, Ma XX, He ZZ. PEAR1 suppresses the proliferation of pulmonary microvascular endothelial cells via PI3K/AKT pathway in ALI model. Microvasc Res. 2020; 128:103941.
|
| 7 |
Vandenbriele C, Kauskot A, Vandersmissen I, Criel M, Geenens R, Craps S, et al. Platelet endothelial aggregation receptor-1: a novel modifier of neoangiogenesis. Cardiovasc Res. 2015; 108(1):124-38.
doi: 10.1093/cvr/cvv193
pmid: 26156496
|
| 8 |
Lewis JP, Ryan K, O’Connell JR, Horenstein RB, Damcott CM, Gibson Q, et al. Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes. Circ Cardiovasc Genet. 2013; 6(2):184-92.
|
| 9 |
Nie XY, Li JL, Qin SB, Fu Y, Liang GK, Shi LW, et al. Genetic mutations in PEAR1 associated with cardiovascular outcomes in Chinese patients with acute coronary syndrome. Thromb Res. 2018; 163:77-82.
|
| 10 |
Stimpfle F, Bauer M, Rath D, Schaeffeler E, Schwab M, Gawaz M, et al. Variants of PEAR1 are associated with outcome in patients with ACS and stable CAD undergoing PCI. Front Pharmacol. 2018; 9:490.
doi: 10.3389/fphar.2018.00490
pmid: 29867494
|
| 11 |
Yao Y, Tang XF, He C, Song Y, Xu JJ, Meng XM, et al. Effect of PEAR1 genetic variants on 1-year outcomes in Chinese patients with acute myocardial infarction after percutaneous coronary intervention. J Atheroscler Thromb. 2018; 25(5):454-9.
doi: 10.5551/jat.39982
pmid: 29212986
|
| 12 |
Yao Y, Tang XF, Zhang JH, He C, Ma YL, Xu JJ, et al. Association of PEAR1 genetic variants with platelet reactivity in response to dual antiplatelet therapy with aspirin and clopidogrel in the Chinese patient population after percutaneous coronary intervention. Thromb Res. 2016; 141:28-34.
doi: 10.1016/j.thromres.2016.02.031
pmid: 26962983
|
| 13 |
Fisch AS, Yerges-Armstrong LM, Backman JD, Wang H, Donnelly P, Ryan KA, et al. Genetic variation in the platelet endothelial aggregation receptor 1 gene results in endothelial dysfunction. PLoS One. 2015; 10(9):e0138795.
|
| 14 |
Faraday N, Yanek LR, Yang XP, Mathias R, Herrera-Galeano JE, Suktitipat B, et al. Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression. Blood. 2011; 118(12):3367-75.
doi: 10.1182/blood-2010-11-320788
pmid: 21791418
|
)
